In patients with NAFLD and in high-fat diet–fed mice, hepatic KISS1/KISS1R expression and plasma kisspeptin levels were elevated, suggesting a compensatory mechanism to reduce triglyceride synthesis. This evidence concerns the gene KISS1 and metabolic dysfunction-associated steatotic liver disease.